Using human induced pluripotent stem cells to model a novel nonsense mutation of RYR2 and identify potential therapeutic agents for patients with CPVT.
- Hopton, C. (Speaker)
Activity: Talk or presentation › Oral presentation
Activity: Talk or presentation › Oral presentation